Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
4.78
Dollar change
-0.04
Percentage change
-0.83
%
IndexRUT P/E202.54 EPS (ttm)0.02 Insider Own3.42% Shs Outstand270.03M Perf Week4.14%
Market Cap1.30B Forward P/E20.25 EPS next Y0.24 Insider Trans-2.68% Shs Float263.01M Perf Month14.35%
Income8.49M PEG5.69 EPS next Q0.01 Inst Own49.32% Short Float11.74% Perf Quarter33.52%
Sales224.60M P/S5.80 EPS this Y370.00% Inst Trans8.21% Short Ratio10.48 Perf Half Y30.96%
Book/sh-0.85 P/B- EPS next Y118.52% ROA2.18% Short Interest30.87M Perf Year1.49%
Cash/sh1.10 P/C4.33 EPS next 5Y35.60% ROE- 52W Range3.17 - 5.75 Perf YTD31.32%
Dividend Est.- P/FCF451.98 EPS past 5Y40.58% ROI7.58% 52W High-16.87% Beta1.27
Dividend TTM- Quick Ratio3.57 Sales past 5Y55.42% Gross Margin70.99% 52W Low50.79% ATR (14)0.18
Dividend Ex-Date- Current Ratio3.84 EPS Y/Y TTM111.30% Oper. Margin13.79% RSI (14)66.16 Volatility3.27% 4.10%
Employees414 Debt/Eq- Sales Y/Y TTM74.92% Profit Margin3.78% Recom1.40 Target Price7.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q188.14% Payout- Rel Volume0.43 Prev Close4.82
Sales Surprise9.44% EPS Surprise53.85% Sales Q/Q63.10% EarningsMay 08 AMC Avg Volume2.95M Price4.78
SMA207.14% SMA507.83% SMA20016.70% Trades Volume1,258,657 Change-0.83%
Date Action Analyst Rating Change Price Target Change
Oct-10-23Initiated Wedbush Outperform $10
May-14-21Initiated RBC Capital Mkts Sector Perform $5
Dec-24-19Initiated Oppenheimer Outperform $2.50
Oct-25-19Initiated Cantor Fitzgerald Overweight $3
May-14-19Initiated BTIG Research Buy $3
Mar-04-19Initiated SVB Leerink Outperform $3
Feb-22-19Initiated SVB Leerink Outperform $3
Feb-28-18Downgrade Maxim Group Hold → Sell $1
Nov-01-17Downgrade Maxim Group Buy → Hold
Oct-10-17Initiated H.C. Wainwright Buy $7
May-13-24 12:00PM
May-10-24 03:01AM
May-09-24 01:46PM
11:47AM
12:15AM
07:30PM Loading…
May-08-24 07:30PM
07:10PM
06:07PM
04:18PM
May-06-24 06:38AM
06:05AM
May-01-24 04:00PM
Apr-30-24 06:05AM
Apr-29-24 11:17AM
06:05AM
06:00AM Loading…
Apr-03-24 06:00AM
Mar-26-24 04:05PM
Mar-25-24 11:45AM
Mar-11-24 06:05AM
Mar-05-24 06:05AM
Mar-04-24 01:01PM
Feb-28-24 09:30AM
08:11AM
01:00AM
Feb-27-24 06:00PM
05:35PM
04:46PM
04:00PM
Feb-20-24 06:00AM
Feb-15-24 06:05AM
12:30PM Loading…
Feb-12-24 12:30PM
Jan-25-24 05:29PM
Jan-02-24 06:05AM
Dec-28-23 06:00AM
Dec-16-23 09:01PM
Nov-08-23 03:27PM
Nov-07-23 09:15PM
05:30PM
04:12PM
04:00PM
Nov-06-23 06:15AM
Nov-01-23 10:01AM
Oct-31-23 04:00PM
Oct-30-23 06:15AM
Sep-07-23 07:08AM
Sep-05-23 06:00AM
Aug-28-23 06:30PM
Aug-14-23 12:44PM
Aug-08-23 05:16PM
11:33AM
12:00AM
Aug-07-23 06:00PM
05:25PM
04:16PM
04:00PM
Aug-01-23 06:00AM
Jul-31-23 04:00PM
Jul-13-23 07:31AM
07:00AM
Jun-22-23 06:05AM
Jun-11-23 08:05AM
May-28-23 07:49PM
May-24-23 08:30AM
May-23-23 09:50AM
May-10-23 12:02PM
06:00AM
May-09-23 11:30PM
08:21PM
05:15PM
04:18PM
04:00PM
01:41PM
May-02-23 05:00PM
Mar-27-23 04:05PM
Mar-14-23 02:26PM
Mar-07-23 05:00PM
Feb-24-23 01:30AM
Feb-23-23 04:00PM
Feb-22-23 06:05AM
Feb-16-23 05:00PM
Feb-15-23 12:46PM
Feb-10-23 05:00PM
Feb-09-23 08:50AM
Jan-24-23 06:00AM
Jan-23-23 06:05AM
Jan-18-23 08:00AM
Jan-17-23 06:36AM
Jan-05-23 06:00AM
Dec-31-22 07:11AM
Dec-06-22 09:55AM
Nov-30-22 12:29PM
Nov-10-22 06:05AM
05:31AM
Nov-08-22 04:30PM
09:15AM
08:00AM
Nov-01-22 06:00AM
Sep-29-22 11:38AM
06:13AM
Sep-21-22 05:00PM
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Binder Steven B.EVP Special ProjectsMay 21 '24Sale4.6625,952120,9361,114,553May 21 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryMay 21 '24Sale4.6623,537109,682873,616May 21 09:00 PM
Binder Steven B.EVP Special ProjectsMay 13 '24Sale4.313,61815,594845,967May 14 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryMay 13 '24Sale4.313,04713,133783,446May 14 09:00 PM
Castagna MichaelChief Executive OfficerDec 15 '23Sale4.0090,482361,9282,148,665Dec 15 09:00 PM
Castagna MichaelChief Executive OfficerDec 14 '23Sale4.00110,000440,0002,239,147Dec 15 09:00 PM
Castagna MichaelChief Executive OfficerNov 01 '23Sale4.2510,00042,5002,349,147Nov 02 09:00 PM
Castagna MichaelChief Executive OfficerOct 02 '23Sale4.6110,00046,1002,359,147Oct 02 09:00 PM
Castagna MichaelChief Executive OfficerSep 01 '23Sale4.6110,00046,1002,436,039Sep 05 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryAug 28 '23Sale4.788,10038,738798,835Aug 28 09:00 PM
Castagna MichaelChief Executive OfficerAug 01 '23Sale4.5710,00045,6862,496,735Aug 01 09:00 PM
Castagna MichaelChief Executive OfficerJul 03 '23Sale4.0710,00040,7012,506,735Jul 05 06:00 AM
Castagna MichaelChief Executive OfficerJun 01 '23Sale4.5310,00045,3022,516,735Jun 02 09:00 PM
Castagna MichaelChief Executive OfficerMay 26 '23Sale4.5075,000337,3352,526,735May 26 09:00 PM
Castagna MichaelChief Executive OfficerMay 25 '23Sale4.5975,000344,4682,601,735May 26 09:00 PM